Nuvalent, Inc. - Class A Common Stock — 재무제표 (NASDAQ:NUVL) | MetaTrader

전체 차트 열기 Full chart

뉴스

Nuvalent: A Precision Oncology Platform With Two Near-Term Shots On Goal (NASDAQ:NUVL)

Nuvation Bio 실적 발표 집중: 입트로지 모멘텀 시험대

Nuvation Bio earnings in focus: Ibtrozi momentum faces test

Does Nuvalent (NUVL) Have the Potential to Rally 37.26% as Wall Street Analysts Expect?

뉴밸런트, 4분기 손실 보고...폐암 치료제 FDA 결정 대기

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Nuvalent, 52주 신고가 경신…112.89 USD 기록

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA, 뉴발렌트의 ROS1 양성 NSCLC 치료제 NDA 접수

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock